Press release
Aptamers Market Size Worth USD 13.5 Billion in 2032 | Emergen Research
Aptamers Market
One of the driving forces behind the market's growth is the escalating prevalence of chronic diseases worldwide. The World Health Organization (WHO) estimates that 71% of global deaths result from chronic diseases such as heart disease, cancer, and diabetes. Aptamers offer promising prospects for revolutionizing chronic disease treatment due to their numerous advantages over traditional therapies, including targeted drug delivery and enhanced specificity.
To Receive A PDF Sample Of The Report, Visit @https://www.emergenresearch.com/request-sample/2692
Moreover, the rising adoption of aptamers over antibodies is expected to bolster market expansion. Aptamers exhibit higher affinity and specificity for their targets, making them preferable for various applications, including diagnostic tests and therapeutic interventions. Their stability across different environmental conditions further enhances their utility in demanding settings.
Technological advancements have significantly augmented the capabilities and applications of aptamers, positioning them as potent tools for therapeutic, diagnostic, and research purposes. High-Throughput Screening (HTS) methods, in particular, have streamlined the process of selecting aptamers, facilitating their broader utilization. Additionally, novel aptamer-based therapeutics, such as Aptamer-Drug Conjugates (ADCs) and aptamer-siRNA conjugates, are poised to drive market growth further.
Leading companies spearheading aptamer development are playing a pivotal role in advancing the market landscape. Collaborations, such as the one between Zentek and McMaster University, underscore the potential of aptamer-based technologies in addressing critical healthcare challenges, such as SARS-CoV-2 infection. These developments signal a paradigm shift in therapeutic approaches, potentially replacing conventional therapies like monoclonal antibodies.
However, the high cost associated with aptamer development presents a notable challenge to market expansion. The time-consuming and labor-intensive nature of the Systematic Evolution of Ligands by Exponential Enrichment (SELEX) process contributes to the elevated costs, hindering the development of aptamers for new targets. Additionally, limited awareness and understanding of aptamers among healthcare professionals and researchers pose further obstacles to market growth.
To Get A Discount On The Latest Report, Visit @https://www.emergenresearch.com/request-discount/2692
Aptamers Top Companies and Competitive Landscape
The global aptamers market is fairly fragmented with many large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing a more effective aptamers products in the market.
• Aptamer Group
• Aptadel Therapeutics
• SomaLogic Operating Co., Inc.
• Base Pair Biotechnologies
• Vivonics, Inc
• Aptagen, LLC
• Aptus Biotech
• TriLink BioTechnologies
• AM BIOTECHNOLOGIES, LLC
• Maravai LifeSciences
Aptamers Latest Industry News
• On 23 May 2022, Aptamer Group announced its partnership with PinotBio for the development of Optimer drug conjugates to target different cancer diseases. This announcement reinforces Cybrexa Therapeutics' commitment to supplying patients by ending the need for chemotherapy in the treatment of breast cancer.
• On 5 March 2021, Aptamer announced its collaboration with AstraZeneca to explore the potential of optimer-based strategies for targeted renal drug delivery. Optimer binders offer a promising solution to this challenge by enabling targeted delivery of drugs to specific renal cells. This collaboration aims to leverage the unique properties of optimer binders to develop novel drug delivery vehicles, known as optimer-drug conjugates.
Browse Detailed Research Report @https://www.emergenresearch.com/industry-report/aptamers-market
Aptamers Market Segment Analysis
For the purpose of this report, Emergen Research has segmented the global aptamers market on the basis of type, technology, Application, end-use, and region:
• Type outlook (Revenue, USD Billion; 2019-2032)
o Nucleic Acid Aptamers
o Peptide Aptamers
• Technology Outlook (Revenue, USD Billion; 2019-2032)
o Systematic Evolution of Ligands By Exponential Enrichment (SELEX)
o Others
• Application Outlook (Revenue, USD Billion; 2019-2032)
o Diagnostic
o Therapeutic
o Research & Development (R&D)
o Others
• End-use Outlook (Revenue, USD Billion; 2019-2032)
o Pharmaceutical & Biotechnology Industry
o Research Institute
o Contract Research Organizations (CROs)
o Others
o
• Regional Outlook (Revenue, USD Billion; 2019-2032)
o North America
1. U.S.
2. Canada
o Europe
1. Germany
2. France
3. UK
4. Italy
5. Spain
6. Benelux
7. Russia
8. Rest of Europe
o Asia Pacific
1. China
2. Japan
3. South Korea
4. India
5. ASEAN Countries
6. Oceania
7. Rest of APAC
o Latin America
1. Brazil
2. Mexico
3. Rest of LATAM
o Middle East & Africa
1. GCC Countries
2. Israel
3. Turkey
4. South Africa
5. Rest of Middle East & Africa
Buy Now: @https://www.emergenresearch.com/select-license/2692
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aptamers Market Size Worth USD 13.5 Billion in 2032 | Emergen Research here
News-ID: 3475272 • Views: …
More Releases from Emergen Research
Global Internet of Things (IoT) in Healthcare Market to Reach USD 299.05 Billion …
The global Internet of Things (IoT) in Healthcare Market was valued at USD 299.05 billion in 2023 and is expected to grow at a CAGR of 16.5% during the forecast period. This growth is fueled by the rising use of connected healthcare devices, increasing demand for early disease detection through remote monitoring, and growing adoption of artificial intelligence (AI) tools within IoT-based healthcare systems.
The market is also benefiting from the…
Global Stem Cell Therapy Market to Reach USD 49.2 Billion by 2034, Growing at 13 …
The global Stem Cell Therapy Market, valued at USD 13.7 billion in 2024, is projected to reach USD 49.2 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.6%. Growth is being fueled by the rising burden of chronic diseases, rapid progress in cell-based studies, and increasing investments in regenerative medicine and personalized healthcare solutions.
Stem cell therapies offer the ability to repair, replace, or restore damaged tissues…
Artificial Intelligence Strengthens Cybersecurity as Threats Grow More Sophistic …
The global Artificial Intelligence in cybersecurity market size was USD 23.8 Billion in 2023 and is expected to reach a market valuation of USD 29.44 billion by the end of 2024 registering a CAGR of 23.7% during the forecast period. The adoption of Artificial Intelligence (AI) in cybersecurity is rapidly gaining traction as organizations worldwide face increasingly complex and frequent cyber threats. By combining advanced technologies such as Machine Learning…
Global Regenerative Medicine Market to Reach USD 125.6 Billion by 2034, Growing …
The global regenerative medicine market, valued at USD 34.2 billion in 2024, is set to grow to USD 125.6 billion by 2034, expanding at a compound annual growth rate (CAGR) of 13.9%. Growth is being fueled by rising approvals of advanced therapies, strong demand for personalized treatments in cancer and orthopedics, and expanding cell and gene therapy manufacturing across major markets such as North America, Europe, and Asia.
Once seen as…
More Releases for Aptamer
Aptamer Market Size 2024 to 2031.
Market Overview and Report Coverage
Aptamers are short, single-stranded nucleic acids or peptides that can bind to specific target molecules with high affinity and specificity. They have gained attention as promising alternative to antibodies in various applications such as diagnostics, therapeutics, and research.
The Aptamer Market is expected to grow at a CAGR of 18.00% during the forecasted period. The increasing research and development activities in the field of aptamers,…
Made-To-Order Aptamer Service Market Incredible Growth, Best Strategies, Future …
"Worldwide Market Reports offers 𝐔𝐩𝐭𝐨 𝟕𝟎% 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭 on Made-To-Order Aptamer Service Market Reports on Single User Access and Unlimited User Access"
The report discusses everything a marketer requires before investing in the global Made-To-Order Aptamer Service during the forecast period 2023-2030. It provides detailed insight into current trends, shares, size, and sales value and volume. The data used for this report is obtained from reliable industry sources, paid resources, and validated…
SELEX Aptamer Selection Process to be the Gold Standard Selection Technique in A …
Though currently limited to the pharmaceutical industry, intense research & development initiatives taken by players in the aptamer market are projected to broaden the existing scope of application of these neoteric molecules to create horizontal market opportunities. With enhanced properties, aptamers are likely to play a pivotal role in environmental monitoring and quality control applications in the agriculture industry.
Click here to Get Synopsis of the Report https://www.factmr.com/report/173/aptamers-market
Currently, a significant volume…
Global Aptamers Market - Industry Trends - Forecast to 2026 || Leading Players - …
Staying informed about the trends and opportunities in the industry is quite a time consuming process where this Aptamers Market report actually helps a lot. The major areas of market analysis such as market definition, market segmentation, competitive analysis and research methodology are studied very carefully and precisely in the whole Aptamers Market report. Various steps are used while generating this report by taking the inputs from a specialized team…
What's Driving Aptamers Market Trends? Key Company Profiled In LLC, Aptagen, LLC …
Aptamers are oligonucleotides or peptide molecules that bind to target lipid, protein, or nucleic acid molecules with a high specificity. Aptamers are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be engineered to have higher affinity and specificity to large number of targets.…
Aptamer Market Scope, On-Going Trends, Demand, Leading Players, Manufactures (AM …
Aptamers are known as special class of molecules which combine the benefits of both low molecular weight as well protein molecules. Over the years, these molecules have fascinated several researchers who are active in various fields of science ranging from analytical chemistry to medicine. To study the overall market expanse for aptamer, a new research study has been added to the broad database of Market Research Reports Search Engine (MRRSE).…
